Backlash on bipolar diagnoses in children

by Boston | July 4, 2007 at 06:48 am
382 views | 0 Recommendations | 0 comments
Part of the criticism of Biederman speaks to a deeper issue in psychiatry: the extensive financial ties between the drug industry and researchers. Biederman has received research funding from 15 drug companies and serves as a paid speaker or adviser to seven of them, including Eli Lilly & Co. and Janssen Pharmaceuticals, which make the multi billion-dollar antipsychotic drugs Zyprexa and Risperdal, respectively. Though not much money was earmarked for bipolar research, critics say the resources help him advance his aggressive drug treatment philosophy.
Advertisement

Comments (0)

This story was created over 3 months ago, the comment thread is now closed.

NowPublic on Facebook

What is NowPublic?

NowPublic lets people work together to cover news events around the world.

Find out more

Most Recommended Stories in Health

 

closeSign in to NowPublic

is reporting from